Evidence map›Paper›PMID 27610935›Full record

Trial reportDrug and alcohol dependence2016

Gender differences in snus versus nicotine gum for cigarette avoidance among a sample of US smokers.

Alicia Allen, Rachel Isaksson Vogel, Ellen Meier, Amanda Anderson, Joni Jensen, Herbert H Severson, Dorothy Hatsukami

Abstract readRandomized Controlled Trial
In one paragraph

Trial report in Drug and alcohol dependence, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Alicia AllenUniversity of Minnesota, Family Medicine and Community Health, Minneapolis, MN, United States; University of Minnesota, Tobacco Research Programs, Minneapolis, MN, United States. Electronic address: alle0299@umn.edu.
Rachel Isaksson VogelUniversity of Minnesota, Gynecologic Oncology, Minneapolis, MN, United States; University of Minnesota, Masonic Comprehensive Cancer Center - Biostatistics and Bioinformatics Core, Minneapolis, MN, United States.
Ellen MeierUniversity of Minnesota, Tobacco Research Programs, Minneapolis, MN, United States.
Amanda AndersonUniversity of Minnesota, Tobacco Research Programs, Minneapolis, MN, United States.
Joni JensenUniversity of Minnesota, Tobacco Research Programs, Minneapolis, MN, United States.
Herbert H SeversonOregon Research Institute, Eugene, OR, United States.
Dorothy HatsukamiUniversity of Minnesota, Tobacco Research Programs, Minneapolis, MN, United States; University of Minnesota, Psychiatry, Minneapolis, MN, United States.

Funding

Women's CancerP30CA077598 · NCI · UNIVERSITY OF MINNESOTA TWIN CITIES · PI Jeffrey S. Miller · 1998 to 2026
$100.4M
University of Minnesota Clinical and Translational Science Institute (UMN CTSI)UL1TR000114 · NCATS · UNIVERSITY OF MINNESOTA · PI BLAZAR, BRUCE R · 2012 to 2015
$35.0M
Tobacco Constituent and Biomarker Assessment CoreU19CA157345 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K · 2012 to 2016
$13.3M
Univ of Minnesota Buidling Interdisciplinary Research Careers in Women's HealthK12HD055887 · NICHD · UNIVERSITY OF MINNESOTA · PI ALLEN, SHARON S, BERGE, JERICA M · 2007 to 2023
$8.6M
Evaluation of Oral Tobacco as a Harm Reduction Method for SmokersR01CA135884 · NCI · UNIVERSITY OF MINNESOTA · PI HATSUKAMI, DOROTHY K · 2008 to 2013
$2.7M
NCATS NIH HHS UL1 TR000114NCI NIH HHS P30 CA077598NCI NIH HHS R01 CA135884NCI NIH HHS U19 CA157345NICHD NIH HHS K12 HD055887
6 · The paper itself

Abstract

introductionWomen are more susceptible to the harmful effects of cigarette smoking. Thus, identifying effective harm reduction approaches for women is necessary. The goal of this project was to examine gender differences in response to snus versus nicotine gum for cigarette avoidance, as a means of harm reduction.

methodsParticipants were randomly assigned to use snus or nicotine gum as a method to avoid cigarette smoking. Participants attended clinic visits to receive study product, as well as provide biological samples to assess smoking avoidance and biomarkers and report on use of study product and cigarettes. A secondary analysis comparing men and women by randomization to study product was conducted.

resultsParticipants (n=391; 47% women) were randomized into the snus group (n=196; 45% women) and the gum group (n=195; 49% women). Men used more snus whereas women used more gum (p=0.02). During treatment, men in the snus group had higher total nicotine equivalent values whereas women did not vary by group (p=0.03). Overall, fewer men in the snus group completely avoided cigarettes compared to men in the gum group (e.g., continuous abstinence at Week 12: odds ratio=0.43, 95% confidence interval=0.20-0.93). Among women, there were no differences by randomization in cigarette avoidance.

conclusionsDespite a number of gender differences in response to snus versus nicotine gum, these data suggest that snus may not be an optimal harm reduction approach for either gender.

Indexed as

Harm ReductionAdultFemaleHumansMaleMiddle AgedNicotineSex FactorsSmokingSmoking CessationTobacco Use Cessation DevicesTobacco Use DisorderNicotineCigarette smokingGender differencesHarm reductionNicotine replacementSnus

Identifiers

PMID27610935
PMCPMC5215723

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.